The Company called the general meeting under short notice authority. The notice of meeting was released only16 days before. However, the intention to call the meeting was announced on 22 August 2019.
There are two items on the agenda: a share buy-back programme and the Directors' remuneration policy. None of these points justify the use of short-term notice.
tem 1: NMC Health seeks approval of a new share buy-back. The Company has an acceptable ability to generate cash flows and debt burden enabling it to comfortably finance the dividends and share buybacks. However, the EPS performance metric is used as one of two LTI performance conditions (50%/50%) and NMC Health only states that it 'may' adjust the measure in case of share cancellation.
Item 2: the proposed remuneration policy missed the general level of information practiced in the UK market. We have mitigated opinion on the policy. On one hand, the Company's performance is exceptional with an acceptable level of remuneration, but on the other hand, we have an excessive variable remuneration (up to 550% of salary in exceptionnal circumstances).
Founded in 1995, Proxinvest is an independent proxy firm supporting the engagement and proxy analysis processes of investors. Proxinvest mission is to analyse corporate governance practices and resolutions proposed at general meetings of listed firms.
Proxinvest main services are :
Proxinvest has been a pioneer and champion of good corporate governance and has grown into a recognised expert in the field.
Proxinvest is independently-owned and only works for investors : Proxinvest does not provide consulting services to the companies it covers, mitigating related risks to its clients and ensuring the independence of our analysis. As a result Proxinvest is able to take a robust, independent, engaged and unconflicted view of the companies in which our clients invest.
As Managing Partner of Expert Corprate Governance Service Ltd (ECGS), Proxinvest has built a large network of corporate governance experts to support clients in corporate governance analysis worldwide.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.